Seminars 2000-2004
| 2020-Present | 2015-2019 | 2010-present | 2005-2009 | 2000-2004 | 1995-1999 | 1990-1994 | 1980-1989 |
“Muscle, Repair Yourself,” University of Iowa Neurology Grand Rounds, Iowa City, Iowa, December 14, 2004.
“Molecular Recognition by LARGE is Essential for Expression of Functional Dystroglycan,” American Society for Matrix Biology, San Diego, California, November 12, 2004.
“Using Mouse Models of Muscular Dystrophies to Develop Therapeutic Strategies,” 43rd Annual Iowa Branch American Association for Laboratory Animal Science, Iowa City, Iowa, October 1, 2004.
“Duchenne Muscular Dystrophy: Molecular Pathogenesis and Therapeutic Strategies,” Muscular Dystrophy Scientific Workshop Toward Therapeutics, Foundation to Eradicate Duchenne, Inc., La Jolla, California, September 18, 2004.
“Glycosylation and Dystroglycan-Matrix Interactions in Muscular Dystrophy,” Gordon Research Conference on Basement Membranes, Bristol, Rhode Island, June 17, 2004.
“Muscle, Repair Yourself,” Howard Hughes Medical Institute Scientific Meeting, Chevy Chase, Maryland, May 25, 2004.
“Muscle, Repair Yourself,” George H. Bishop Lecture Series, Washington University, St. Louis, Missouri, May 20, 2004.
“Molecular Basis of Muscular Dystrophy,” University of Rochester, Rochester, New York, May 14, 2004.
“Molecular Basis of Muscular Dystrophy.” American Academy of Neurology Plenary Session, Frontiers in Clinical Neuroscience-Beyond the Decade of the Brain,” San Francisco, California, April 29, 2004.
“Glycosylation and Dystroglycan Function in Congenital Muscular Dystrophy with Brain Abnormalities,” University of California, San Diego, California, April 27, 2004.
“Molecular Organization and Function of Dystroglycan,” University of Washington Department of Biochemistry, Seattle, Washington, April 15, 2004.
“Molecular Basis of Muscular Dystrophy and Approaches to Therapy,” Ohio State University Research Day, Columbus, Ohio, April 1, 2004.
“Molecular Basis of Muscular Dystrophy and Approaches to Therapy” Cincinnati Children’s Hospital Medical Center Rachford Lecture, Cincinnati, Ohio, March 31, 2004.
“Dystroglycan, Dysferlin, and Cardiomyopathy.” Keystone Symposium on Molecular Biology and Cardiac Disease, Keystone, Colorado, March 11, 2004.
“Glycosylation and Dystroglycan Function in Congenital Muscular Dystrophy with Brain Abnormalities.” University of Pennsylvania Children’s Hospital, Philadelphia, Pennsylvania, February 10, 2004.
“Muscle: Repair Yourself.” Keynote Speaker, New Directions in Biology and Disease of Skeletal Muscle, San Diego, California, January 25, 2004.
"New Insights into the Pathogenesis of Muscular Dystrophy,” University of Minnesota, Minneapolis, MN, June 13, 2003.
“Glycosylation and Dystroglycan Function in Congenital Muscular Dystrophy with Brian Abnormalities”, Columbia University Neurology Grand Rounds, New York, NY, June 11, 2003.
"Molecular Basis of Muscular Dystrophy and Approaches to Therapy", Iowa Academy of Science Annual Meeting, Des Moines, IA, April 26th, 2003.
"New Insights into the Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy”, Pediatric Cardiology Core Curriculum Seminar, University of Iowa, Iowa City, IA, April 22nd, 2003.
“Molecular Insights into the Pathogenesis of Muscular Dystrophy”, Ramsey Lecture, Virginia Commonwealth University, Richmond, VA, April 10th, 2003.
“Glycosylation and Dystroglycan Function in Congenital Muscular Dystrophy”, HHMI 2003 Scientific Meeting, Chevy Chase, MD, April 1st, 2003.
“Molecular Insights into the Pathogenesis of Muscular Dystrophy”, 9th Annual Mini-Retreat in Muscle Biology, University of Maryland, Baltimore, MD, March 14th, 2003.
“Molecular Aspects of Muscle Biology”, Department of Neurology, Neuroscience Lecture, University of Iowa, Iowa City, IA, March 7th, 2003.
“Post-translational Processing and Functional Disruption of Dystroglycan in Congenital Muscular Dystrophy with Developmental Brain Abnormalities”, San Raffaele Scientific Institute, Milan, Italy, January 21st, 2003.
“Role of a-dystroglycan in Congenital Muscular Dystrophy”, 3rd Workshop of The ENMC Myo-Cluster Project, Naarden, The Netherlands, January 17th-19th, 2003.
“Molecular Basis of Muscular Dystrophy and Associated Cardiomyopathy“, President’s Symposium for the Association of University Cardiologists Meeting, Carmel, CA, January 9th, 2003.
“Dystroglycan—EMC Interactions in Cardiomyopathy”, Therapeutic Horizons in Heart Failure Conference, La Jolla, CA, December 7th, 2002.
“New Insights in to the Pathogenesis of Muscular Dystrophy”, MBI Seminar, UCLA, Los Angeles, CA, December 5th, 2002.
“Role of Dystroglycan in Matrix Assembly” American Society for Matrix Biology, Houston, TX, November 7th, 2002.
“Molecular Insights into the Pathogenesis of Muscular Dystrophy” Korean Society for Molecular and Cellular Biology, Seoul, Korea, October 18th, 2002.
“New Insights into the Pathogenesis of Muscular Dystrophy” MacLennan Symposium, Toronto, October 3rd, 2002.
"Sarcoglycans” Landmark Lecture for the ISHR Annual Meeting, Madison, WI, July 26th, 2002.
"Gene Therapy in Limb-Girdle Muscular Dystrophy” MDA Special Session, 10th International Congress On Neuromuscular Diseases, Vancouver, B.C., July 9th, 2002.
"Dystrophin-Glycoprotein Complex and Company” 10th International Congress On Neuromuscular Diseases, Vancouver, B.C., July 8th, 2002.
"Tissue Specific Disruption of Dystroglycan” Basement Membranes in Diseases Session, Gordon Research Conference, Plymouth, NH, June 9th-13th, 2002.
"Gene Transfer as a Tool to Understand the Pathogenesis of Muscular Dystrophy” American Society of Gene Therapy Annual Meeting, Boston, MA, June 8th, 2002.
"Peripheral Neuropathy with Folded Myelin Sheaths in Mice Lacking Schwann Cell Dystroglycan” 4th WMMN Meeting, Bar Harbor, ME, June 7th, 2002.
"Tissue Specific Disruption of Dystroglycan Function”, Department of Biological Sciences, University of Iowa, Iowa City, Iowa, April 26th, 2002.
"Animal Models of Dysferlinopathy” and “Pathological and Immunological Features of Dysferlin Deficient Muscle” 105th ENMC Workshop on LGMD, Naarden, Netherlands, April 12-14th. 2002.
"New Insights into the Pathogenesis of Muscular Dystrophy” University of Pennsylvania, Mini-Symposium on Neuromuscular Diseases, Philadelphia, PA, March 11th, 2002.
"Molecular Insights Into the Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy" Pediatric Grand Rounds, University of Iowa, Iowa City, Iowa, March 1st, 2002.
"Tissue Specific Disruption of Dystroglycan Function” UCSD/HHMI Seminar Series, San Diego, CA, February 11th, 2002.
"Tissue Specific Disruption of Dystroglycan Function” Duke University Medical School, Raleigh, NC, February 5, 2002.
"Tissue Specific Disruption of Dystroglycan: Insights into Muscular Dystrophy”, ASCB Meeting, Washington, D.C., December 12th, 2001.
"Mouse Models of Muscular Dystrophy: Molecules and Mechanisms”, University of Pennsylvania, Philadelphia, PA, December 3rd, 2001.
"New Insights into the Pathogenesis of Muscular Dystrophy”, UIHC Department of Neurology Grand Rounds, Iowa City, IA, November 27, 2001.
"Molecular Basis of Muscular Dystrophy and Approaches to Therapy”, Avigen, Alameda, CA, November 14th, 2001.
"Tissue Specific Disruption of Dystroglycan Function”, Pathogenesis Affinity Group Seminar, Scripps Research Institute, La Jolla, CA, November 13th, 2001.
"Cytoskeletal Protein Deficiency in Mice: Insights into Mechanisms of Cardiomyopathy”, American Heart Association Meeting, Anaheim, CA, November 12th, 2001.
"Molecular Organization and Function of Brain Dystroglycan in the Nervous System” Society for Neuroscience Symposium, San Diego, CA, November 11th, 2001.
"Mouse Models of Muscular Dystrophy: Molecules and Mechanisms” Fred Fay Lecture Series, University of Massachusetts, October 29th, 2001.
"Dystroglycan: an Extracellular Matrix Receptor and Its Role In Muscular Dystrophy” Memorial Sloan Kettering Cancer Center, New York, NY, October 26th, 2001.
"Molecular Organization and Function of Brain Dystroglycan” American Society of Human Genetics Meeting, San Diego, CA, October 14th, 2001.
"Molecular Insights Into the Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy” University of Michigan, Ann Arbor, MI, September 28th, 2001.
"The Role of Biochemistry in Discovering Pathogenetic Mechanisms of the Muscular Dystrophies” World muscle Society Meeting, Snowbird, Utah, September 6th, 2001.
"Identification and Functional Characterization of Subunit Interaction Sites in Voltage-Gated Calcium Channels” Pharmacia & Upjohn, Kalamazoo, MI, August 15th, 2001.
"Molecular Pathogeneis of Muscular Dystrophy and Associated Cardiomyopathy” NIH Seminar, Washington, D.C., June 21st, 2001.
"Molecular Pathogenesis of Muscular Dystrophy and Approaches to Therapy” NIAMS Retreat, Warrenton, VA, June 5th, 2001.
"Mouse Models of Muscular Dystrophy: Molecules and Mechanisms” Gordon Research Conference on Myogenesis, Lucca, Italy, May 2nd, 2001.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy” University of Virginia, Charlottesville, VA, April 9th, 2001.
"Gene Transfer of LGMD”, Experimental Biology 2001 Meeting, Orlando, FL, March 31st, 2001.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy”, UTSW Lecture Series Seminar, Dallas, TX, March 28th, 2001.
"Molecular Organization and Function of Dystroglycan in Muscle and Brain”, UTSW Neuroscience Lecture Series Seminar, Dallas, TX, March 27th, 2001.
"Mouse Models of Muscular Dystrophy: Molecules and Mechanisms”, HHMI Scientific Meeting, Chevy Chase, MD, March 7th, 2001.
"Mouse Models of Muscular Dystrophy: Molecules and Mechanisms", University of Illinois at Urbana-Champaign, IL, February 23rd, 2001.
"Genetic Aspects of Muscular Dystrophy” AACN Meeting, New Orleans, LA, February 12th, 2001.
"Molecular Pathogenesis and Therapeutic Approaches to Muscular Dystrophy” Skirball Institute, NYU, New York, NY, February 6th, 2001.
"Molecular Pathogenesis and Therapeutic Approaches for Muscular Dystrophy” Columbia University, New York, NY, February 5th, 2001.
"Dystrophin and Muscular Dystrophy” Cytokinetics Subgroup Seminar at the American Society for Cell Biology Meeting, San Francisco, CA, December 9th, 2000.
"Mechanisms in Cardiomyopathy and Musucular Dystrophy” SUNY Downstate Medical Center, Brooklyn, NY, November 2nd, 2000.
"Prevention of the Cardiomyopathic Phenotype in Genetic a Mouse Model” Bristol Meyers Squibb, Princeton, NJ, November 1st, 2000.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy” University of Arizona, Tucson, AZ , October 23rd, 2000.
"Molecular Organization of the Dystrophin-Glycoprotein Complex in Skeletal, Cardiac and Smooth Muscle” Special Lecture for G. Conte Prize, MSM Congress Meeting, Capri, Italy, October 1st, 2000.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy" MyoContract Pharmaceutical Research, University of Basel, Basel, Switzerland, September 27th, 2000.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy" Geneva University Hopsitals, Department of Geriatrics, Geneva, Switzerland, September 24th, 2000.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy" University Medical Center, Bernheim Laboratory, Geneva, Switzerland, September 24th, 2000.
"Dystroglycan: A Critical Mediator of Basement Membrane Assembly in Development and Disease.” Basement Membrane Gordon Conference, Conneticut College, New London, CT, June 22, 2000.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy.” Neurology Grand Rounds, University of Pennsylvania, Philadelphia, PA, June 8, 2000.
"Mouse Models of Muscular Dystrophy and Cardiomyopathy: Molecules, Muscles and Mechanisms.” Pennsylvania Muscle Institute Seminar, University of Pennslyvania, June 2, 2000.
"Dystroglycan and Basement Membrane Assembly in Development and Disease.” Abrahmson Cancer Institute, University of Pennsylvania, June 1, 2000.
"Molecular Basis of Limb-Girdle Muscular Dystrophy and Approaches to Therapy.” Asilomar Conference “Molecular Biology of Muscle Development and Disease,” May 21, 2000.
"Dystroglycan, the Extracellular Matrix Receptor, and its Role in Muscular Dystrophy.” Northwestern University Seminar, Chicago, IL, May 9, 2000.
"Molecular Organization and Function of Dystrophin-Glycoprotein Complex in Skeletal, Cardiac and Smooth Muscle.” Association Française contre les Myopathies Meeting, Nice, France, March 29 – April 1, 2000.
"Molecular Pathogenesis of Muscular Dystrophy and Associated Cardiomyopathy.” HHMI Scientific Meeting, Chevy Chase, MD, March 27, 2000.
"Genetics of Cardiac and Skeletal Myopathies.” A Day of Molecular Medicine, The Salk Institute/The University of California, San Diego, CA, March 21, 2000.
"Mouse Models of Muscular Dystrophy: Molecules and Mechanisms.” COE Symposium 2000 on Muscular Dystrophy, Tokyo, Japan, March 13-17, 2000.
"Molecular Interactions of Dystroglycan with Basement Membrane Molecules and Infectious Agents.” Keystone Symposium – Cell Biology of the Virus, Taos, NM, March 1, 2000.
"Molecular Pathogenesis and Gene Therapy for Limb Girdle Muscular Dystrophy.” University of Wisconsin, Madison, WI, February 22, 2000.
"Sarcoglycan Complex in Vascular Smooth Muscle: Role in the Pathogenesis of Cardiomyopathy and Muscular Dystrophy.” 44th Annual Biophysical Society Meeting, New Orleans, LA, February 14, 2000.
"Dystroglycan: A Critical Mediator of Cytoskeleton – Extracellular Matrix Interactions in Development and Disease.” Keystone Symposium – Dynamics of Cytoskeleton, Keystone, CO, February 8, 2000.